
Full profile: /officials/P000034
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-11-20
Source: Congress.gov
Currently in
Previously
This bill aims to reduce what Americans pay for prescription medications through various policy changes, though the specific measures haven't been detailed yet since it's still in the early committee review stage. The proposal would likely affect patients who buy drugs, pharmaceutical companies that manufacture them, and possibly insurance companies and healthcare providers involved in drug pricing. Once the relevant committees examine their portions of the bill, they'll determine what tools—such as price negotiations, generic drug incentives, or out-of-pocket cost limits—would actually be used to bring down drug prices.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.